Peter Gierschik

4PUBLICATIONS
12CO-AUTHORS
Molecular targetsMedical molecular engineering of nucleic acids and proteinsOphthalmologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 09, 2026
PLCG2 exon-skipped variants: insights into their potential role in chronic lymphocytic leukemia.

|Jan 20, 2023
Acquired BTK mutations associated with resistance to noncovalent BTK inhibitors.

Jialei Qi, Sascha Endres, Deyan Yordanov Yosifov

|Feb 16, 2022
Compound heterozygous variants in OTULIN are associated with fulminant atypical late-onset ORAS.

Julia Zinngrebe, Barbara Moepps, Thomas Monecke

|Oct 18, 2021
Evaluation of vecabrutinib as a model for noncovalent BTK/ITK inhibition for treatment of chronic lymphocytic leukemia.

Billy Michael Chelliah Jebaraj, Annika Müller, Rashmi Priyadharshini Dheenadayalan

Pageof 1

Frequent Collaborators

3 joint publications

Billy Michael Chelliah Jebaraj

3 joint publications

Sascha Endres

3 joint publications

Jialei Qi

2 joint publications

Daniel Mertens